I have read the Research and Markets' Privacy Policy and consent to the processing of my personal data.*

RECENTLY VIEWED PRODUCTS

TESTIMONIALS

The Service I received from the Orders and Customer Service Team was very professional. Their responses were very quick and actioned on immediately.

Mr Gueorgui TzvetanovSenior ManagerERGO Austria International AG

The Research and Markets’ customer support team provided me with timely and immediate responses and delivered exactly the information that I was looking for – great job. Thank you very much. I would recommend them to anybody who is looking for market research data.

Great customer service and super responsive. I was having issues with my payment method but Claire in customer service was super responsive to help several times until the issue was entirely resolved. Great job

Mr Detlef RethagePresidentNitto Avecia Inc

The reports ordered are of good quality and are relevant to our business needs.

Mr Etienne AdriansenSenior Director Business EvaluationLEO Pharma

Thank you for all of your help! I think your service is excellent. It is an easy platform to order interesting reports.

Mr Tomi AmberlaConsultantPöyry Management Consulting

The team at Research and Markets are first rate. Their market intelligence is relevant and accurate and the customer service fast, responsive and dependable. I always benefit from knowledge gained from their comprehensive studies and will continue to utilize their services.

Ms Liz DickinsonCEOPhysical Enterprises Inc

I have bought reports from other sources but the report that I bought from Research and Markets was the most detailed of the lot. Their customer service was excellent and I was able to get the report without any fuss.

Mr Naveed KamalAsst Manager: Business DevelopmentRangs Group Ltd

Celebrating 15
years in business
by partnering
with UNICEF for education

FEATURED COMPANIES

BV is a vaginal disease caused due to complex alteration of flora present in the vagina. Antibacterial drugs are used for the treatment of BV, some of the most common drugs used for the treatment of the disease include Metronidazole, Clindamycin, and Tinidazole. The drugs are used in both oral and topical forms. Two types of bacteria are found in the genital parts of the women, termed as good bacteria and bad bacteria. The good bacteria present in the vagina are lactobacilli, which prevents the growth of bad bacteria.

The analysts forecast the global bacterial vaginosis drugs market to grow at a CAGR of 2.16% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global bacterial vaginosis drugs market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

The report, Global Bacterial Vaginosis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Bayer

Pfizer

Sanofi

Starpharma Holdings

Other prominent vendors

Allergan

AstraZeneca

Cardinal Health

Mylan

Novartis

Sun Pharmaceutical Industries

Symbiomix Therapeutics

Teva Pharmaceutical Industries

Market drivers

Unmet demand in BV treatment market

For a full, detailed list, view the full report

Market challenges

Development of resistance against antibiotics

For a full, detailed list, view the full report

Market trends

Growing awareness about controlled use of antibiotics

For a full, detailed list, view the full report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.

Commenting on the report, an analyst from the research team said: “One trend in the market is growing awareness about controlled use of antibiotics. Antibiotic resistance is one of the major problems being faced by the medical world today. It is a condition wherein an microorganism changes itself and remains no longer sensitive to that particular antibiotic. Thus, the antibiotic will no longer be capable of killing or inhibiting the growth of bacteria.”

According to the report, one driver in the market is unmet demand in BV treatment market. Unmet demand in the treatment of BV has created great opportunity for the market players. There is huge unmet need in the treatment of BV, especially the recurrent form of the disease. BV is the most common vaginal infection in the women of child bearing age group. Despite being highly prevalent in nature, little has been done in the field. When left untreated, it may lead to severe infections, especially in the case of pregnant women such as preterm births.

Further, the report states that one challenge in the market is development of resistance against antibiotics. The development of multidrug-resistant microbes is one of the major threats to the human health. The microbe changes itself to protect against the antimicrobial agent used and thereby develops resistance to the drug. This develops largely due to the irrational use of drugs. Incorrect prescription of the drugs by physicians or incorrect dosing or course taken by patients leads to the development of resistant drugs. This occurs because of the increased accumulation of drugs in the body. The commonly used antibiotic drugs thus become ineffective against microbes, leading to aggravation of disease in the body.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.